Viridian Therapeutics, Inc. Common Stock
€14.59
EUR
Last updated on --.
24h volume1.26M
24h highest15.5705 EUR
24h lowest14.5308 EUR
24h Price movement-1.45%
VRDN recent prices
24 Hours
-1.45%-€0.21483
30 days
+25.85%+€2.998
60 days
-37.11%-€8.735
90 days
-42.39%-€10.75
Key data
Previous close14.8143 EUR
Market cap1.67B EUR
Volume1.26M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.3631 EUR
Net income (FY)-309.85M EUR
Revenue (FY)60.94M EUR
Last report dateMay 5, 2026
About Viridian Therapeutics, Inc. Common Stock
HeadquartersWALTHAM
Employees (FY)252.00
Revenue per employee (FY)241.82K EUR
Net income per employee (FY)-1.23M EUR
Listed onNasdaq
VRDN conversion tables
 |  |
|---|---|
| 0.5 VRDN | 7.299 EUR |
| 1 VRDN | 14.59 EUR |
| 5 VRDN | 72.99 EUR |
| 10 VRDN | 145.99 EUR |
| |
|---|---|
| 0.5 EUR | 0.034248 VRDN |
| 1 EUR | 0.068495 VRDN |
| 5 EUR | 0.34248 VRDN |
| 10 EUR | 0.68495 VRDN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
VRDN is trading at €14.59, -1.45% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VRDN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VRDN is currently trading at €14.59, -1.45% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VRDN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VRDN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VRDN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VRDN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Viridian Therapeutics, Inc. Common Stock's market cap is currently 1.67B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.26M
24h highest15.5705 EUR
24h lowest14.5308 EUR
24h Price movement-1.45%
Start trade with VRDN Perpetual
Sign up to trade